Precision medicine will find new application to population health initiatives, but those efforts are early in the development process.
Payers and health systems will increasingly work together to apply precision medicine findings to different population health models.
There’s still a ways to go, says Lili Brillstein, director of episodes of care for the market innovations division of Horizon Blue Cross Blue Shield of New Jersey.
